On September 30, 2022, Further, Living Cell Technologies announced that it has sent the notice of the 2022 annual general meeting of shareholders will be held on November 10, 2022. In addition, the Company urged the shareholders to vote for the appointment of David Richard Hainsworth and Bradley John Dilkes as directors; and vote against the resolutions the removal of Bernard Touch, Andrew Kelly and Robert Moyse Willcocks as Directors; and the removal of interim appointed directors.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.011 AUD | -4.35% | 0.00% | +10.00% |
Mar. 08 | Algorae Pharmaceuticals Nears Launch of Drug Discovery Platform | MT |
Feb. 28 | Algorae Pharmaceuticals Limited Reports Earnings Results for the Half Year Ended December 31, 2023 | CI |
1st Jan change | Capi. | |
---|---|---|
+10.00% | 12.41M | |
+9.42% | 115B | |
+11.84% | 106B | |
-1.05% | 21.96B | |
-14.15% | 21.84B | |
-5.29% | 19.21B | |
-4.16% | 18.08B | |
-38.29% | 17.71B | |
+7.99% | 14.32B | |
+36.24% | 12.42B |
- Stock Market
- Equities
- 1AI Stock
- News Algorae Pharmaceuticals Limited
- Living Cell Technologies Send Notice of Annual General Meeting